Stock listing
Cnbx Pharmaceuticals Inc.
Selected listing: CNBX · OTC · USD · US
Cnbx Pharmaceuticals Inc. (OTC:CNBX), Health Technology. Latest release Nov 8, 2022: CNBX to Enter the Cancer Immunotherapy Market After Acquiring…
- Ticker
- OTC:CNBX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Cnbx Pharmaceuticals Inc.
Cnbx Pharmaceuticals Inc. is a public company traded under the ticker CNBX in the American market. Cnbx aims to address unmet medical needs through its research and development efforts.
Latest news from Cnbx Pharmaceuticals Inc.
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
November 8, 2022
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
October 18, 2022
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel
October 13, 2022
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate
September 29, 2022
CNBX Pharmaceuticals Announces New Patent Granted in Australia
September 28, 2022
Research Cnbx Pharmaceuticals Inc.
Cnbx Pharmaceuticals Inc. company profile
View the public company page for Cnbx Pharmaceuticals Inc. on 6ix.
Cnbx Pharmaceuticals Inc. news
Read company news and market updates connected to Cnbx Pharmaceuticals Inc..
Cnbx Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Cnbx Pharmaceuticals Inc..